rs1554913069
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000352.6(ABCC8):c.2835_2838delGAGA(p.Arg946LysfsTer95) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000352.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461888Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Reported in association with congenital hyperinsulinism (Stanley et al., 2004; Martinez et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23275527, 14715863, 27188453) -
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 556981). This premature translational stop signal has been observed in individual(s) with congenital hyperinsulinism (PMID: 14715863, 23275527). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg946Lysfs*95) in the ABCC8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCC8 are known to be pathogenic (PMID: 20685672, 23345197). -
DNA sequence analysis of the ABCC8 gene demonstrated two sequence changes. The first sequence change is a four base pair deletion in exon 24, c.2835_2838del. This likely pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 95 amino acids downstream of the change , p.Arg946Lysfs*95. This likely pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated ABCC8 protein with potentially abnormal function. The c.2835_2838del sequence change has not been described in population databases such as ExAC and gnomAD. This sequence change has been reported in congenital hyperinsulinism (PMID: 14715863). This sequence change is the likely cause of this individual's phenotype, however functional studies have not been performed to prove this conclusively. -
Hyperinsulinemic hypoglycemia, familial, 1 Pathogenic:2
Variant summary: ABCC8 c.2835_2838delGAGA (p.Arg946LysfsX95) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (c.2992C>T (p.Arg998X), c.3574delG (p.Asp1192fsX16)). The variant was absent in 251486 control chromosomes (gnomAD). c.2835_2838delGAGA has been reported in the literature in individuals affected with Congenital Hyperinsulinism (CH)(Martinez_2016, Snider_2013). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submission (evaluation after 2014) cites the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
Neonatal diabetes mellitus Other:1
This variant is found to be a potent moderate impact, variant with a CADD score of 22.8 and sufficient scientific evidence of gene-disease correlation. However, since this is not a high impact variant and no variant evidence, this variant is reclassified as Uncertain risk allele. -
Maturity onset diabetes mellitus in young Other:1
This variant is found to be a potent moderate impact variant with a CADD score of 22.8 and sufficient scientific evidence to support gene-disease correlation. However, since this is not a high impact variant and has no variant evidence, this variant is reclassified as Uncertain Risk Allele -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at